The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months
BACKGROUND: We report the update of the Tor Vergata immunosuppression (IS) weaning
protocol in stable hepatitis C virus (HCV) liver transplant (LT) recipients. METHODS: The
weaning off IS was attempted in 34 patients who had received a LT 63.5±20.1 months
earlier, for HCV-related end stage liver disease. Patients were observed over a period of 6.5
years. During this time, yearly protocol liver biopsies were performed. Primary endpoints
were determined as the feasibility of weaning off IS and its impact on the long term disease …
protocol in stable hepatitis C virus (HCV) liver transplant (LT) recipients. METHODS: The
weaning off IS was attempted in 34 patients who had received a LT 63.5±20.1 months
earlier, for HCV-related end stage liver disease. Patients were observed over a period of 6.5
years. During this time, yearly protocol liver biopsies were performed. Primary endpoints
were determined as the feasibility of weaning off IS and its impact on the long term disease …